BridgeBio Pharma Announces Pricing of Its Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
BridgeBio Pharma, Inc. (BBIO) IPO Opens at $30.61 After Pricing at $17
June 27, 2019 11:08 AM EDTBridgeBio Pharma's (NASDAQ: BBIO) IPO opened at $30.61 after pricing 20,500,000 shares of its common stock at a price to the public of $17 per share.
J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, Jefferies LLC, SVB Leerink LLC, KKR Capital Markets LLC, Piper... More
